(Q40239376)

English

A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy

scientific article published on August 2006

Statements

A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit